SAKAR2025-07-012025-09-30SAKAR2025-09-30SAKAR2025-03-31SAKAR2025-04-012025-09-30SAKAR2025-07-012025-09-30in-capmkt:OtherExpenses1MemberSAKAR2025-04-012025-09-30in-capmkt:OtherExpenses1MemberSAKAR2025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1SAKAR2025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain1SAKAR2025-06-30RelatedPartyTransactionDomain1SAKAR2025-09-30RelatedPartyTransactionDomain1SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain2SAKAR2025-06-30RelatedPartyTransactionDomain2SAKAR2025-09-30RelatedPartyTransactionDomain2SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain3SAKAR2025-06-30RelatedPartyTransactionDomain3SAKAR2025-09-30RelatedPartyTransactionDomain3SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain4SAKAR2025-06-30RelatedPartyTransactionDomain4SAKAR2025-09-30RelatedPartyTransactionDomain4SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain5SAKAR2025-06-30RelatedPartyTransactionDomain5SAKAR2025-09-30RelatedPartyTransactionDomain5SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain6SAKAR2025-06-30RelatedPartyTransactionDomain6SAKAR2025-09-30RelatedPartyTransactionDomain6SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain7SAKAR2025-06-30RelatedPartyTransactionDomain7SAKAR2025-09-30RelatedPartyTransactionDomain7SAKAR2025-07-012025-09-30RelatedPartyTransactionDomain8SAKAR2025-06-30RelatedPartyTransactionDomain8SAKAR2025-09-30RelatedPartyTransactionDomain80000002025-09-30Statement10000002025-07-012025-09-30Statement1SAKAR2025-09-30StatementDynamic1I1Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000SAKARNOTLISTEDINE732S01012Sakar Healthcare LimitedMain BoardEquity2025-04-012026-03-312025-11-072025-11-03INRLakhsQuarterlySecond quarterSingle segmentPharmaceuticals2025-11-0711:30:002025-11-0712:30:00trueCash Flow IndirectNot applicabletruetrueNANAfalsetrue2025-05-1515-05-2025true1falseAS ON DATE NOT APPLICABLE2025-07-012025-09-30UnauditedStandalone57560400012146000587750000296101000079630008341900015268000568380007458200053417100053579000053579000081810008181000045398000000045398000-26700045131000222499000102.032.03002.032.03 <BR> 1 The Company is operating only in one segment. Hence segment reporting is not given. <BR> <BR> 2 The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder. <BR> <BR> 3 The Company has a wholly owned subsidiary vis. M/s. Sakar Oncology Private Limited. Other than this, the Company does not have any subsidiary/ associate. <BR> <BR> 4 Provision for taxation/deferred taxation, if any, will be made at the year end. <BR> <BR> 5 Figures, wherever required, are regrouped / rearranged. <BR> <BR> 6 The above results have been reviewed by audit committee and approved by Board of Directors of Company at its meeting held on 7th November, 2025. <BR> <BR> <BR> Please note that for Quarter ended 30-09-2025, the Current tax is Rs. 100.90 lacs and MAT Credit Entitlement is Rs. (100.90 lacs) hence the net effect is NIL. And for year ended 30-09-2025, the Current tax is Rs. 191.19 lacs and MAT Credit Entitlement is Rs. (191.19 lacs) hence the net effect is NIL2025-04-012025-09-30UnauditedStandalone110296600016085000111905100058367400009914000158915000366940001125610001098660001011624000107427000010742700001531600015316000092111000000092111000-53400091577000222499000104.144.14004.144.14Other expenses74582000Other expenses10986600031711700001703360000765640001000003006000310600011861100035397870004452650000319852000640002077000772000322765000179014000947044000448683100022249900028108820003033381000303338100045256000045256000027419000996410005796200002660550000360277000360277000132200000758532000937930000215050008738300001453450000448683100035538000-9341000-128470000-37989000-1129140000001496110000001125610000177940000524500003166200000000000-2280000226297000333724000000278530000305871000000000000273995000000000000000000000000-27399500000864000000000008338200000355380000-288000-32808000-9320000-93200099600064000Re-measurement gains/(losses) on defined benefit plans-370000-370000Re-measurement gains/(losses) on defined benefit plans-740000-740000-103000-20600000-267000-534000SAKAR HEALTHCARE LIMITED******Sanjay S. Shah******Managing DirectorRemuneration9000000Approved900000000SAKAR HEALTHCARE LIMITED******Rita S. Shah******Non-Executive DirectorRemuneration900000Approved90000000SAKAR HEALTHCARE LIMITED******Aarsh S. Shah******Joint Managing DirectorRemuneration7200000Approved720000000SAKAR HEALTHCARE LIMITED******Ayushi S. Shah******Administrative ExecutiveRemuneration0Approved000SAKAR HEALTHCARE LIMITED******Dharmesh Thakkar******CFORemuneration570000Approved57000000SAKAR HEALTHCARE LIMITED******Bharat Soni******CSRemuneration335000Approved33500000SAKAR HEALTHCARE LIMITED******Aarsh S. Shah******Joint Managing DirectorLoan0000SAKAR HEALTHCARE LIMITED******Sanjay S. Shah******Managing DirectorLoan000018005000Preferential Issues2025-06-17864000002025-09-30falsefalseSANJAY SHAHManaging DirectorAHMEDABAD2025-11-07Capital expenditure for Procurement of Lipid Complex Injections Machinery and Equipments/Utilities with electrification for Oncology unitNA709350000709350000The Funds have been utilized in total